分子洞察力胃癌入侵-当前状态和未来方向的分子洞察力
Tasuku Matsuoka1, Masakazu Yashiro1
1Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, Osaka 5458585, Japan.
Cancers
|January 11, 2024
概括
胃癌 (GC) 侵袭机制复杂,阻碍了有效的第四阶段治疗. 了解分子驱动因素和瘤微环境相互作用是开发新型,多目标疗法的关键,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃癌 (GC) 是全球领先的恶性瘤,IV期患者的预后不佳.
- 目前的向疗法 (例如,HER2,免疫检查点抑制剂) 由于对GC进展的不完全理解,其有效性有限.
- 侵袭和转移是推动GC死亡率的关键特征.
研究的目的:
- 审查和总结关于GC入侵分子机制的当前知识.
- 突出新兴的治疗策略,针对GC中的入侵可塑性.
主要方法:
- 对基因组研究和瘤微环境相互作用的综合文献综述 侵袭性GC中的瘤微环境相互作用.
- 对基因细胞入侵和转移的分子机制的分析.
主要成果:
- 基因组研究已经确定了侵袭性GC中的失调基因产物.
- 瘤微环境相互作用是GC入侵和转移的关键驱动因素.
- 了解这些分子参与者为GC发展提供了洞察力.
结论:
- 更深入地了解GC入侵机制对于改善患者存活率至关重要.
- 未来的治疗策略应侧重于针对侵袭可塑性的多疗法方法.
- 新的策略可能比传统的单一目标疗法提供更有前途的结果.
更多相关视频
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Integrins
4.0K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.0K


